Hemostatic Effects of Glucono-Delta-Lactone

Glucono-delta-lactone (GDL) can be used to mediate the human blood coagulation process. In particular, GDL can be used in an assay to determine an individual's risk potential for accelerated blood clotting or as a treatment for conditions related to accelerated clotting potential and/or inflammatory states.

Patents:
US 20,110,071,219

Inventor(s): SPILLERT CHARLES R [US]; PERSAUD DEBBIE [US]

Type of Offer: Licensing



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent